Tetranychus truncatus Ehara (Acari: Tetranychidae) is one of the serious pests that infests different agricultural crops in field and greenhouse crops, and its distribution is limited to mostly Asian countries. The experiments were conducted to know the effectiveness of different concentrations of bifenazate against the T. truncatus, and to evaluate and compare the demographic parameters of T. truncatus on host plant Lablab purpureus (L.) Sweet (Fabaceae), which were obtained from females treated with bifenazate. The LC15, LC30, LC50 and LC90 values are determined through the bioassay from the results of the first application of bifenazate on adult females of T. truncatus. The LC15, LC30, LC50 and LC90 concentrations of bifenazate were 0.417, 1.028, 2.591 and 24.792 ml/l, respectively. The response of adult females against the two lethal concentrations (LC15 and LC30) was mostly alike but had a little bit difference. The differences in life table parameters were observed between control and treated spider mites. The results demonstrated that LC15 and LC30 of bifenazate could reduce the survival rate, oviposition period, fecundity and longevity of females of T. truncatus and it significantly affected the developmental times, especially larval duration and fecundity of T. truncatus. Life-table parameters of T. truncatus were much reduced in LC15 and LC30 compared to the control and their growth and other factors showed significant differences. The present study showed that the lower lethal concentration (LC15 and LC30) of the tested acaricide showed negative effects on survivorship and life-table parameters of the subsequent generation of T. truncatus.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.